FDA Inspection 1312102 — Phibro Suzhou Manufacturing Co., Ltd.
The FDA completed an inspection of Phibro Suzhou Manufacturing Co., Ltd. on May 29, 2024 in Suzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 29, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Suzhou (China)
Additional Details
Mutual Recognition Agreement (MRA)